DNA modification therapy
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
456
NCT02070198
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
Phase: Phase 4
Role: Lead Sponsor
Start: Dec 31, 2013
Completion: Dec 31, 2014
NCT02201914
Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF
Start: Jan 31, 2014
Completion: Nov 30, 2014
NCT02084940
Long Acting GnRH Antagonist in PCOS Women Undergoing IVF
Phase: N/A
Start: Mar 31, 2014
Completion: Feb 28, 2015
NCT07200193
A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
Phase: Phase 1/2
Start: Jan 1, 2026
Completion: Dec 31, 2032
Loading map...